Quantitative analysis of aberrant p16 methylation using real-time quantitative methylation-specific polymerase chain reaction.
Cancer Res
; 59(16): 3899-903, 1999 Aug 15.
Article
in En
| MEDLINE
| ID: mdl-10463578
ABSTRACT
We have developed a quantitative method for methylation analysis of the p16 gene based on real-time methylation-specific PCR (MSP). Real-time MSP is sensitive enough to detect down to 10 genome equivalents of the methylated p16 sequence. Application of real-time MSP to DNA from tumor-derived cell lines revealed complete concordance with conventional MSP analysis. Quantitative data generated by real-time MSP were expressed as the methylation index, which was defined as the percentage of bisulfite-converted DNA that consisted of methylated target sequences. The methylation index was shown to be inversely correlated with p16 gene transcription during demethylation treatment of cell lines with 5-aza-2'-deoxycytidine. The application of real-time MSP to bone marrow aspirates from patients with multiple myeloma revealed complete concordance with conventional MSP analysis. Real-time quantitative MSP may have applications in elucidating diverse biological processes involving DNA methylation and may become a valuable diagnostic tool for detecting tumor-associated epigenetic changes in cancer patients.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Polymerase Chain Reaction
/
DNA Methylation
/
Genes, p16
Type of study:
Diagnostic_studies
Limits:
Humans
Language:
En
Journal:
Cancer Res
Year:
1999
Document type:
Article
Publication country:
EEUU
/
ESTADOS UNIDOS
/
ESTADOS UNIDOS DA AMERICA
/
EUA
/
UNITED STATES
/
UNITED STATES OF AMERICA
/
US
/
USA